+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Blood Banking Market by Blood Component Type, Testing Type, Donor Type, Collection Method, Application, End User - Global Forecast 2026-2032

  • Report

  • 193 Pages
  • June 2026
  • Region: Global
  • 360iResearch™
  • ID: 6083942
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Blood Banking Market is projected to reach USD 21.55 Billion in 2026. It is expected to continue growing at a CAGR of 8.58%, reaching USD 35.38 Billion by 2032.

Blood banking is a mission-critical healthcare infrastructure segment that supports surgery, trauma care, oncology, obstetrics, hematology, transplant medicine, and disaster response. The World Health Organization reports approximately 118.5 million blood donations globally, with high-income countries collecting about 40% of donations despite representing roughly 16% of the global population, underscoring persistent access and utilization gaps.

For industry leaders, the blood banking market is shaped by safe blood collection, component processing, infectious disease testing, cold-chain logistics, inventory optimization, and regulatory compliance. Demand remains resilient because red blood cells, platelets, plasma, and specialized blood products are essential, time-sensitive therapies with limited substitutes.

Transformative Shifts in the Blood Banking Landscape

The blood banking landscape is shifting from volume-based collection toward precision supply management, traceability, and outcome-linked transfusion practices. Hospitals and blood centers are increasing reliance on leukoreduction, nucleic acid testing, pathogen reduction technologies, automated component processing, and digital donor engagement to improve safety, availability, and donor retention.

Regulatory expectations are also rising. Quality management systems, hemovigilance, donor screening, biologics compliance, and electronic records are becoming central to operational resilience as health systems face aging populations, variable donor participation, extreme weather disruptions, and growing need for rare blood types and platelet availability.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is becoming a cumulative force across blood banking by improving donor targeting, appointment scheduling, inventory forecasting, demand prediction, compatibility support, and transport routing. When validated against historical transfusion, expiry, and hospital utilization data, AI can help reduce wastage and strengthen matching between collection plans and clinical need.

The highest-value applications are decision-support tools rather than fully autonomous systems. Responsible deployment requires audited datasets, bias monitoring, cybersecurity controls, clinical validation, regulatory documentation, and human oversight because blood products are biologics used in high-risk care environments.

Key Regional Insights: Blood Banking Demand and Infrastructure

North America and Europe remain advanced blood banking regions due to mature hospital networks, strong hemovigilance, established regulatory and professional frameworks, and broad adoption of automated testing, component processing, and electronic traceability. North America emphasizes resilience after recurring supply shortages and weather-related disruptions, while Europe benefits from cross-border quality alignment, national transfusion services, and regionwide safety requirements for blood and blood components.

Asia-Pacific is expanding blood banking capability as China, India, Japan, Australia, and South Korea invest in hospital capacity, voluntary donation systems, digital health infrastructure, and advanced infectious disease testing. Latin America continues strengthening national coordination, with Brazil and Mexico acting as major demand centers for transfusion services across public and private healthcare settings. The Middle East, led by GCC health investment, is modernizing centralized blood services, high-acuity hospital capacity, and emergency preparedness, while Africa remains focused on improving voluntary donation rates, screening coverage, cold-chain reach, and equitable access to safe blood.

Key Group Insights: ASEAN, GCC, EU, BRICS, G7, and NATO

ASEAN markets are advancing blood safety through regional health cooperation, donor education, quality system upgrades, and laboratory modernization, although infrastructure maturity varies widely across member states. The GCC is prioritizing centralized blood services, digital health integration, high-acuity care capacity, and emergency response readiness. The European Union benefits from harmonized quality, safety, traceability, and vigilance expectations for blood and blood components, supporting consistent transfusion standards across member countries.

BRICS countries represent a major growth base for blood banking because of population scale, urban hospital expansion, surgical volumes, cancer care development, and rising transfusion demand in Brazil, Russia, India, China, and South Africa. G7 countries lead in automation, quality systems, rare blood programs, patient blood management, and advanced testing adoption. NATO members increasingly view blood supply continuity as part of emergency preparedness, disaster response, military-civilian health resilience, and strategic medical logistics.

Key Country Insights: Major Blood Banking Markets

The United States and Canada have mature voluntary donation systems, sophisticated infectious disease testing, strong hospital transfusion governance, and established hemovigilance practices, while Mexico and Brazil are expanding modernization across collection networks, laboratory capacity, and public-private healthcare delivery. In Europe, the United Kingdom, Germany, France, Italy, and Spain operate high-standard blood systems supported by national quality frameworks, component therapy, donor screening, and patient blood management, while Russia maintains large-scale national capacity with regional variability in access and infrastructure.

China and India are high-priority blood banking markets because of population size, surgical demand, cancer care expansion, maternal health needs, and ongoing efforts to increase voluntary non-remunerated donation. Japan, Australia, and South Korea demonstrate advanced quality systems, automation, hemovigilance, and aging-population demand patterns, making them important benchmarks for safe, technology-enabled blood banking and hospital transfusion management.

Actionable Recommendations for Industry Leaders

Industry leaders should invest in interoperable blood management platforms that connect donor recruitment, appointment scheduling, laboratory testing, inventory, hospital ordering, transfusion records, and hemovigilance data. Forecasting models should be paired with clinician-led patient blood management programs to reduce avoidable transfusions while protecting availability for trauma, oncology, obstetrics, hematology, and emergency care.

Strategic priorities include diversifying donor pools, expanding rare blood registries, strengthening platelet logistics, improving cold-chain visibility, validating AI tools, and building redundancy in reagents, consumables, and transport capacity. Partnerships with hospitals, regulators, emergency agencies, donor organizations, and community groups are essential for improving resilience, equity, and public trust.

Research Methodology

This executive summary is based on triangulation of publicly available and industry-recognized sources, including the World Health Organization, national blood authorities, FDA and European regulatory guidance, AABB and ISBT standards, peer-reviewed transfusion medicine literature, hospital utilization trends, and health infrastructure indicators.

The methodology emphasizes verified secondary research, regulatory review, market signal analysis, and cross-validation across regional, group, and country-level healthcare data. Insights are framed to support executive decision-making without relying on unverified market estimates, market sizing, market share assumptions, or unsupported projections.

Conclusion

Blood banking is evolving from a collection-centered service into a digitally enabled, quality-driven healthcare infrastructure market. Safety, availability, traceability, and resilience are now defining operational and public health priorities across mature and emerging systems.

Organizations that combine validated automation, responsible AI, regulatory excellence, donor trust, equitable access strategies, and clinically aligned inventory management will be best positioned to improve access, reduce wastage, and support the rising global need for safe blood and blood components.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Blood Banking Market, by Blood Component Type
7.1. Cryoprecipitate
7.2. Plasma
7.3. Platelets
7.4. Red Blood Cells
7.5. Whole Blood
8. Blood Banking Market, by Testing Type
8.1. Blood Grouping Testing
8.2. Infectious Disease Testing
9. Blood Banking Market, by Donor Type
9.1. Family Replacement Donor
9.2. Paid Donor
9.3. Voluntary Donor
10. Blood Banking Market, by Collection Method
10.1. Whole Blood Collection
10.2. Apheresis Collection
10.2.1. Plateletpheresis
10.2.2. Plasmapheresis
10.2.3. Leukapheresis
11. Blood Banking Market, by Application
11.1. Diagnostics
11.2. Research
11.3. Transfusion
12. Blood Banking Market, by End User
12.1. Ambulatory Surgical Centers
12.2. Blood Banks
12.3. Hospitals And Clinics
13. Asia-Pacific Blood Banking Market
14. Europe Blood Banking Market
15. North America Blood Banking Market
16. Latin America Blood Banking Market
17. Africa Blood Banking Market
18. Middle East Blood Banking Market
19. NATO Blood Banking Market
20. G7 Blood Banking Market
21. European Union Blood Banking Market
22. BRICS Blood Banking Market
23. ASEAN Blood Banking Market
24. GCC Blood Banking Market
25. United States Blood Banking Market
26. China Blood Banking Market
27. Germany Blood Banking Market
28. Japan Blood Banking Market
29. India Blood Banking Market
30. United Kingdom Blood Banking Market
31. France Blood Banking Market
32. Canada Blood Banking Market
33. Italy Blood Banking Market
34. Australia Blood Banking Market
35. South Korea Blood Banking Market
36. Brazil Blood Banking Market
37. Mexico Blood Banking Market
38. Russia Blood Banking Market
39. Spain Blood Banking Market
40. Competitive Landscape
40.1. Market Concentration Analysis, 2025
40.1.1. Concentration Ratio (CR)
40.1.2. Herfindahl Hirschman Index (HHI)
40.2. Recent Developments & Impact Analysis, 2025
40.3. Product Portfolio Analysis, 2025
40.4. Benchmarking Analysis, 2025
41. Company Profiles
41.1. Abbott Laboratories
41.2. Arctiko A/S
41.3. BAG Diagnostics GmbH
41.4. Baxter International Inc.
41.5. Beckman Coulter, Inc.
41.6. Becton Dickinson and Company
41.7. Bio-Rad Laboratories, Inc.
41.8. Cardinal Health, Inc.
41.9. Cerus Corporation
41.10. F. Hoffmann-La Roche Ltd.
41.11. Fresenius Kabi AG
41.12. Grifols S.A.
41.13. Haemonetics Corporation
41.14. Helmer Scientific, Inc.
41.15. ICU Medical, Inc.
41.16. Immucor, Inc.
41.17. JMS Transfusion Technology CO., LTD.
41.18. Labcold Ltd.
41.19. Macopharma SA
41.20. Nipro Corporation
41.21. QuidelOrtho Corporation
41.22. Sarstedt AG & Co. KG
41.23. Siemens Healthineers AG
41.24. Span Healthcare Private Limited
41.25. Terumo BCT, Inc.
41.26. Thermo Fisher Scientific Inc.
41.27. Tulip Diagnostics (P) Ltd.
41.28. WellSky Corporation
List of Figures
FIGURE 1. GLOBAL BLOOD BANKING MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL BLOOD BANKING MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL BLOOD BANKING MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL BLOOD BANKING MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL BLOOD BANKING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 6. GLOBAL BLOOD BANKING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 7. GLOBAL BLOOD BANKING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL BLOOD BANKING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 9. GLOBAL BLOOD BANKING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL BLOOD BANKING MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 11. GLOBAL BLOOD BANKING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL BLOOD BANKING MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 13. GLOBAL BLOOD BANKING MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
FIGURE 14. GLOBAL BLOOD BANKING MARKET SIZE, BY BLOOD COMPONENT TYPE, 2025 VS 2032 (%)
FIGURE 15. GLOBAL BLOOD BANKING MARKET SIZE, BY BLOOD COMPONENT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL BLOOD BANKING MARKET SIZE, BY TESTING TYPE, 2025 VS 2032 (%)
FIGURE 17. GLOBAL BLOOD BANKING MARKET SIZE, BY TESTING TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2025 VS 2032 (%)
FIGURE 19. GLOBAL BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL BLOOD BANKING MARKET SIZE, BY COLLECTION METHOD, 2025 VS 2032 (%)
FIGURE 21. GLOBAL BLOOD BANKING MARKET SIZE, BY COLLECTION METHOD, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL BLOOD BANKING MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 23. GLOBAL BLOOD BANKING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. GLOBAL BLOOD BANKING MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 25. GLOBAL BLOOD BANKING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 26. ASIA-PACIFIC BLOOD BANKING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 27. ASIA-PACIFIC BLOOD BANKING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 28. EUROPE BLOOD BANKING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 29. EUROPE BLOOD BANKING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 30. NORTH AMERICA BLOOD BANKING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 31. NORTH AMERICA BLOOD BANKING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 32. LATIN AMERICA BLOOD BANKING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 33. LATIN AMERICA BLOOD BANKING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 34. AFRICA BLOOD BANKING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 35. AFRICA BLOOD BANKING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 36. MIDDLE EAST BLOOD BANKING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 37. MIDDLE EAST BLOOD BANKING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 38. NATO BLOOD BANKING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 39. NATO BLOOD BANKING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 40. G7 BLOOD BANKING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 41. G7 BLOOD BANKING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 42. EUROPEAN UNION BLOOD BANKING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 43. EUROPEAN UNION BLOOD BANKING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 44. BRICS BLOOD BANKING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 45. BRICS BLOOD BANKING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 46. ASEAN BLOOD BANKING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 47. ASEAN BLOOD BANKING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 48. GCC BLOOD BANKING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 49. GCC BLOOD BANKING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 50. UNITED STATES BLOOD BANKING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 51. CHINA BLOOD BANKING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 52. GERMANY BLOOD BANKING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 53. JAPAN BLOOD BANKING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 54. INDIA BLOOD BANKING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 55. UNITED KINGDOM BLOOD BANKING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 56. FRANCE BLOOD BANKING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 57. CANADA BLOOD BANKING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 58. ITALY BLOOD BANKING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 59. AUSTRALIA BLOOD BANKING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 60. SOUTH KOREA BLOOD BANKING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 61. BRAZIL BLOOD BANKING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 62. MEXICO BLOOD BANKING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 63. RUSSIA BLOOD BANKING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 64. SPAIN BLOOD BANKING MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL BLOOD BANKING MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL BLOOD BANKING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL BLOOD BANKING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL BLOOD BANKING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL BLOOD BANKING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL BLOOD BANKING MARKET SHARE, BY KEY PLAYER, 2025
TABLE 7. GLOBAL BLOOD BANKING MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
TABLE 8. GLOBAL BLOOD BANKING MARKET SIZE, BY BLOOD COMPONENT TYPE, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL CRYOPRECIPITATE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL CRYOPRECIPITATE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL CRYOPRECIPITATE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL PLASMA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL PLASMA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL PLASMA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL PLATELETS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL PLATELETS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL PLATELETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL RED BLOOD CELLS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL RED BLOOD CELLS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL RED BLOOD CELLS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL WHOLE BLOOD MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL WHOLE BLOOD MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL WHOLE BLOOD MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL BLOOD BANKING MARKET SIZE, BY TESTING TYPE, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL BLOOD GROUPING TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL BLOOD GROUPING TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL BLOOD GROUPING TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL INFECTIOUS DISEASE TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL INFECTIOUS DISEASE TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL INFECTIOUS DISEASE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL FAMILY REPLACEMENT DONOR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL FAMILY REPLACEMENT DONOR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL FAMILY REPLACEMENT DONOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL PAID DONOR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL PAID DONOR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL PAID DONOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL VOLUNTARY DONOR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL VOLUNTARY DONOR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL VOLUNTARY DONOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL BLOOD BANKING MARKET SIZE, BY COLLECTION METHOD, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL WHOLE BLOOD COLLECTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL WHOLE BLOOD COLLECTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL WHOLE BLOOD COLLECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL APHERESIS COLLECTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL APHERESIS COLLECTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL APHERESIS COLLECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL PLATELETPHERESIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL PLATELETPHERESIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL PLATELETPHERESIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL PLASMAPHERESIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL PLASMAPHERESIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL PLASMAPHERESIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL LEUKAPHERESIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL LEUKAPHERESIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL LEUKAPHERESIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL RESEARCH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL RESEARCH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL RESEARCH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL TRANSFUSION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL TRANSFUSION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL TRANSFUSION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL BLOOD BANKING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL BLOOD BANKS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL BLOOD BANKS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL BLOOD BANKS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL HOSPITALS AND CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL HOSPITALS AND CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL HOSPITALS AND CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 77. ASIA-PACIFIC BLOOD BANKING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 78. ASIA-PACIFIC BLOOD BANKING MARKET SIZE, BY BLOOD COMPONENT TYPE, 2018-2032 (USD MILLION)
TABLE 79. ASIA-PACIFIC BLOOD BANKING MARKET SIZE, BY TESTING TYPE, 2018-2032 (USD MILLION)
TABLE 80. ASIA-PACIFIC BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2018-2032 (USD MILLION)
TABLE 81. ASIA-PACIFIC BLOOD BANKING MARKET SIZE, BY COLLECTION METHOD, 2018-2032 (USD MILLION)
TABLE 82. ASIA-PACIFIC BLOOD BANKING MARKET SIZE, BY APHERESIS COLLECTION, 2018-2032 (USD MILLION)
TABLE 83. ASIA-PACIFIC BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 84. ASIA-PACIFIC BLOOD BANKING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 85. EUROPE BLOOD BANKING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 86. EUROPE BLOOD BANKING MARKET SIZE, BY BLOOD COMPONENT TYPE, 2018-2032 (USD MILLION)
TABLE 87. EUROPE BLOOD BANKING MARKET SIZE, BY TESTING TYPE, 2018-2032 (USD MILLION)
TABLE 88. EUROPE BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2018-2032 (USD MILLION)
TABLE 89. EUROPE BLOOD BANKING MARKET SIZE, BY COLLECTION METHOD, 2018-2032 (USD MILLION)
TABLE 90. EUROPE BLOOD BANKING MARKET SIZE, BY APHERESIS COLLECTION, 2018-2032 (USD MILLION)
TABLE 91. EUROPE BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 92. EUROPE BLOOD BANKING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 93. NORTH AMERICA BLOOD BANKING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 94. NORTH AMERICA BLOOD BANKING MARKET SIZE, BY BLOOD COMPONENT TYPE, 2018-2032 (USD MILLION)
TABLE 95. NORTH AMERICA BLOOD BANKING MARKET SIZE, BY TESTING TYPE, 2018-2032 (USD MILLION)
TABLE 96. NORTH AMERICA BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2018-2032 (USD MILLION)
TABLE 97. NORTH AMERICA BLOOD BANKING MARKET SIZE, BY COLLECTION METHOD, 2018-2032 (USD MILLION)
TABLE 98. NORTH AMERICA BLOOD BANKING MARKET SIZE, BY APHERESIS COLLECTION, 2018-2032 (USD MILLION)
TABLE 99. NORTH AMERICA BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 100. NORTH AMERICA BLOOD BANKING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 101. LATIN AMERICA BLOOD BANKING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 102. LATIN AMERICA BLOOD BANKING MARKET SIZE, BY BLOOD COMPONENT TYPE, 2018-2032 (USD MILLION)
TABLE 103. LATIN AMERICA BLOOD BANKING MARKET SIZE, BY TESTING TYPE, 2018-2032 (USD MILLION)
TABLE 104. LATIN AMERICA BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2018-2032 (USD MILLION)
TABLE 105. LATIN AMERICA BLOOD BANKING MARKET SIZE, BY COLLECTION METHOD, 2018-2032 (USD MILLION)
TABLE 106. LATIN AMERICA BLOOD BANKING MARKET SIZE, BY APHERESIS COLLECTION, 2018-2032 (USD MILLION)
TABLE 107. LATIN AMERICA BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 108. LATIN AMERICA BLOOD BANKING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 109. AFRICA BLOOD BANKING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 110. AFRICA BLOOD BANKING MARKET SIZE, BY BLOOD COMPONENT TYPE, 2018-2032 (USD MILLION)
TABLE 111. AFRICA BLOOD BANKING MARKET SIZE, BY TESTING TYPE, 2018-2032 (USD MILLION)
TABLE 112. AFRICA BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2018-2032 (USD MILLION)
TABLE 113. AFRICA BLOOD BANKING MARKET SIZE, BY COLLECTION METHOD, 2018-2032 (USD MILLION)
TABLE 114. AFRICA BLOOD BANKING MARKET SIZE, BY APHERESIS COLLECTION, 2018-2032 (USD MILLION)
TABLE 115. AFRICA BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 116. AFRICA BLOOD BANKING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 117. MIDDLE EAST BLOOD BANKING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 118. MIDDLE EAST BLOOD BANKING MARKET SIZE, BY BLOOD COMPONENT TYPE, 2018-2032 (USD MILLION)
TABLE 119. MIDDLE EAST BLOOD BANKING MARKET SIZE, BY TESTING TYPE, 2018-2032 (USD MILLION)
TABLE 120. MIDDLE EAST BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2018-2032 (USD MILLION)
TABLE 121. MIDDLE EAST BLOOD BANKING MARKET SIZE, BY COLLECTION METHOD, 2018-2032 (USD MILLION)
TABLE 122. MIDDLE EAST BLOOD BANKING MARKET SIZE, BY APHERESIS COLLECTION, 2018-2032 (USD MILLION)
TABLE 123. MIDDLE EAST BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 124. MIDDLE EAST BLOOD BANKING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 125. NATO BLOOD BANKING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 126. NATO BLOOD BANKING MARKET SIZE, BY BLOOD COMPONENT TYPE, 2018-2032 (USD MILLION)
TABLE 127. NATO BLOOD BANKING MARKET SIZE, BY TESTING TYPE, 2018-2032 (USD MILLION)
TABLE 128. NATO BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2018-2032 (USD MILLION)
TABLE 129. NATO BLOOD BANKING MARKET SIZE, BY COLLECTION METHOD, 2018-2032 (USD MILLION)
TABLE 130. NATO BLOOD BANKING MARKET SIZE, BY APHERESIS COLLECTION, 2018-2032 (USD MILLION)
TABLE 131. NATO BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 132. NATO BLOOD BANKING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 133. G7 BLOOD BANKING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 134. G7 BLOOD BANKING MARKET SIZE, BY BLOOD COMPONENT TYPE, 2018-2032 (USD MILLION)
TABLE 135. G7 BLOOD BANKING MARKET SIZE, BY TESTING TYPE, 2018-2032 (USD MILLION)
TABLE 136. G7 BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2018-2032 (USD MILLION)
TABLE 137. G7 BLOOD BANKING MARKET SIZE, BY COLLECTION METHOD, 2018-2032 (USD MILLION)
TABLE 138. G7 BLOOD BANKING MARKET SIZE, BY APHERESIS COLLECTION, 2018-2032 (USD MILLION)
TABLE 139. G7 BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 140. G7 BLOOD BANKING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 141. EUROPEAN UNION BLOOD BANKING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 142. EUROPEAN UNION BLOOD BANKING MARKET SIZE, BY BLOOD COMPONENT TYPE, 2018-2032 (USD MILLION)
TABLE 143. EUROPEAN UNION BLOOD BANKING MARKET SIZE, BY TESTING TYPE, 2018-2032 (USD MILLION)
TABLE 144. EUROPEAN UNION BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2018-2032 (USD MILLION)
TABLE 145. EUROPEAN UNION BLOOD BANKING MARKET SIZE, BY COLLECTION METHOD, 2018-2032 (USD MILLION)
TABLE 146. EUROPEAN UNION BLOOD BANKING MARKET SIZE, BY APHERESIS COLLECTION, 2018-2032 (USD MILLION)
TABLE 147. EUROPEAN UNION BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 148. EUROPEAN UNION BLOOD BANKING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 149. BRICS BLOOD BANKING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 150. BRICS BLOOD BANKING MARKET SIZE, BY BLOOD COMPONENT TYPE, 2018-2032 (USD MILLION)
TABLE 151. BRICS BLOOD BANKING MARKET SIZE, BY TESTING TYPE, 2018-2032 (USD MILLION)
TABLE 152. BRICS BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2018-2032 (USD MILLION)
TABLE 153. BRICS BLOOD BANKING MARKET SIZE, BY COLLECTION METHOD, 2018-2032 (USD MILLION)
TABLE 154. BRICS BLOOD BANKING MARKET SIZE, BY APHERESIS COLLECTION, 2018-2032 (USD MILLION)
TABLE 155. BRICS BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 156. BRICS BLOOD BANKING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 157. ASEAN BLOOD BANKING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 158. ASEAN BLOOD BANKING MARKET SIZE, BY BLOOD COMPONENT TYPE, 2018-2032 (USD MILLION)
TABLE 159. ASEAN BLOOD BANKING MARKET SIZE, BY TESTING TYPE, 2018-2032 (USD MILLION)
TABLE 160. ASEAN BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2018-2032 (USD MILLION)
TABLE 161. ASEAN BLOOD BANKING MARKET SIZE, BY COLLECTION METHOD, 2018-2032 (USD MILLION)
TABLE 162. ASEAN BLOOD BANKING MARKET SIZE, BY APHERESIS COLLECTION, 2018-2032 (USD MILLION)
TABLE 163. ASEAN BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 164. ASEAN BLOOD BANKING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 165. GCC BLOOD BANKING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 166. GCC BLOOD BANKING MARKET SIZE, BY BLOOD COMPONENT TYPE, 2018-2032 (USD MILLION)
TABLE 167. GCC BLOOD BANKING MARKET SIZE, BY TESTING TYPE, 2018-2032 (USD MILLION)
TABLE 168. GCC BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2018-2032 (USD MILLION)
TABLE 169. GCC BLOOD BANKING MARKET SIZE, BY COLLECTION METHOD, 2018-2032 (USD MILLION)
TABLE 170. GCC BLOOD BANKING MARKET SIZE, BY APHERESIS COLLECTION, 2018-2032 (USD MILLION)
TABLE 171. GCC BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 172. GCC BLOOD BANKING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 173. UNITED STATES BLOOD BANKING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 174. UNITED STATES BLOOD BANKING MARKET SIZE, BY BLOOD COMPONENT TYPE, 2018-2032 (USD MILLION)
TABLE 175. UNITED STATES BLOOD BANKING MARKET SIZE, BY TESTING TYPE, 2018-2032 (USD MILLION)
TABLE 176. UNITED STATES BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2018-2032 (USD MILLION)
TABLE 177. UNITED STATES BLOOD BANKING MARKET SIZE, BY COLLECTION METHOD, 2018-2032 (USD MILLION)
TABLE 178. UNITED STATES BLOOD BANKING MARKET SIZE, BY APHERESIS COLLECTION, 2018-2032 (USD MILLION)
TABLE 179. UNITED STATES BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 180. UNITED STATES BLOOD BANKING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 181. CHINA BLOOD BANKING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 182. CHINA BLOOD BANKING MARKET SIZE, BY BLOOD COMPONENT TYPE, 2018-2032 (USD MILLION)
TABLE 183. CHINA BLOOD BANKING MARKET SIZE, BY TESTING TYPE, 2018-2032 (USD MILLION)
TABLE 184. CHINA BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2018-2032 (USD MILLION)
TABLE 185. CHINA BLOOD BANKING MARKET SIZE, BY COLLECTION METHOD, 2018-2032 (USD MILLION)
TABLE 186. CHINA BLOOD BANKING MARKET SIZE, BY APHERESIS COLLECTION, 2018-2032 (USD MILLION)
TABLE 187. CHINA BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 188. CHINA BLOOD BANKING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 189. GERMANY BLOOD BANKING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 190. GERMANY BLOOD BANKING MARKET SIZE, BY BLOOD COMPONENT TYPE, 2018-2032 (USD MILLION)
TABLE 191. GERMANY BLOOD BANKING MARKET SIZE, BY TESTING TYPE, 2018-2032 (USD MILLION)
TABLE 192. GERMANY BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2018-2032 (USD MILLION)
TABLE 193. GERMANY BLOOD BANKING MARKET SIZE, BY COLLECTION METHOD, 2018-2032 (USD MILLION)
TABLE 194. GERMANY BLOOD BANKING MARKET SIZE, BY APHERESIS COLLECTION, 2018-2032 (USD MILLION)
TABLE 195. GERMANY BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 196. GERMANY BLOOD BANKING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 197. JAPAN BLOOD BANKING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 198. JAPAN BLOOD BANKING MARKET SIZE, BY BLOOD COMPONENT TYPE, 2018-2032 (USD MILLION)
TABLE 199. JAPAN BLOOD BANKING MARKET SIZE, BY TESTING TYPE, 2018-2032 (USD MILLION)
TABLE 200. JAPAN BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2018-2032 (USD MILLION)
TABLE 201. JAPAN BLOOD BANKING MARKET SIZE, BY COLLECTION METHOD, 2018-2032 (USD MILLION)
TABLE 202. JAPAN BLOOD BANKING MARKET SIZE, BY APHERESIS COLLECTION, 2018-2032 (USD MILLION)
TABLE 203. JAPAN BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 204. JAPAN BLOOD BANKING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 205. INDIA BLOOD BANKING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 206. INDIA BLOOD BANKING MARKET SIZE, BY BLOOD COMPONENT TYPE, 2018-2032 (USD MILLION)
TABLE 207. INDIA BLOOD BANKING MARKET SIZE, BY TESTING TYPE, 2018-2032 (USD MILLION)
TABLE 208. INDIA BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2018-2032 (USD MILLION)
TABLE 209. INDIA BLOOD BANKING MARKET SIZE, BY COLLECTION METHOD, 2018-2032 (USD MILLION)
TABLE 210. INDIA BLOOD BANKING MARKET SIZE, BY APHERESIS COLLECTION, 2018-2032 (USD MILLION)
TABLE 211. INDIA BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 212. INDIA BLOOD BANKING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 213. UNITED KINGDOM BLOOD BANKING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 214. UNITED KINGDOM BLOOD BANKING MARKET SIZE, BY BLOOD COMPONENT TYPE, 2018-2032 (USD MILLION)
TABLE 215. UNITED KINGDOM BLOOD BANKING MARKET SIZE, BY TESTING TYPE, 2018-2032 (USD MILLION)
TABLE 216. UNITED KINGDOM BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2018-2032 (USD MILLION)
TABLE 217. UNITED KINGDOM BLOOD BANKING MARKET SIZE, BY COLLECTION METHOD, 2018-2032 (USD MILLION)
TABLE 218. UNITED KINGDOM BLOOD BANKING MARKET SIZE, BY APHERESIS COLLECTION, 2018-2032 (USD MILLION)
TABLE 219. UNITED KINGDOM BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 220. UNITED KINGDOM BLOOD BANKING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 221. FRANCE BLOOD BANKING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 222. FRANCE BLOOD BANKING MARKET SIZE, BY BLOOD COMPONENT TYPE, 2018-2032 (USD MILLION)
TABLE 223. FRANCE BLOOD BANKING MARKET SIZE, BY TESTING TYPE, 2018-2032 (USD MILLION)
TABLE 224. FRANCE BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2018-2032 (USD MILLION)
TABLE 225. FRANCE BLOOD BANKING MARKET SIZE, BY COLLECTION METHOD, 2018-2032 (USD MILLION)
TABLE 226. FRANCE BLOOD BANKING MARKET SIZE, BY APHERESIS COLLECTION, 2018-2032 (USD MILLION)
TABLE 227. FRANCE BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 228. FRANCE BLOOD BANKING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 229. CANADA BLOOD BANKING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 230. CANADA BLOOD BANKING MARKET SIZE, BY BLOOD COMPONENT TYPE, 2018-2032 (USD MILLION)
TABLE 231. CANADA BLOOD BANKING MARKET SIZE, BY TESTING TYPE, 2018-2032 (USD MILLION)
TABLE 232. CANADA BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2018-2032 (USD MILLION)
TABLE 233. CANADA BLOOD BANKING MARKET SIZE, BY COLLECTION METHOD, 2018-2032 (USD MILLION)
TABLE 234. CANADA BLOOD BANKING MARKET SIZE, BY APHERESIS COLLECTION, 2018-2032 (USD MILLION)
TABLE 235. CANADA BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 236. CANADA BLOOD BANKING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 237. ITALY BLOOD BANKING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 238. ITALY BLOOD BANKING MARKET SIZE, BY BLOOD COMPONENT TYPE, 2018-2032 (USD MILLION)
TABLE 239. ITALY BLOOD BANKING MARKET SIZE, BY TESTING TYPE, 2018-2032 (USD MILLION)
TABLE 240. ITALY BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2018-2032 (USD MILLION)
TABLE 241. ITALY BLOOD BANKING MARKET SIZE, BY COLLECTION METHOD, 2018-2032 (USD MILLION)
TABLE 242. ITALY BLOOD BANKING MARKET SIZE, BY APHERESIS COLLECTION, 2018-2032 (USD MILLION)
TABLE 243. ITALY BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 244. ITALY BLOOD BANKING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 245. AUSTRALIA BLOOD BANKING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 246. AUSTRALIA BLOOD BANKING MARKET SIZE, BY BLOOD COMPONENT TYPE, 2018-2032 (USD MILLION)
TABLE 247. AUSTRALIA BLOOD BANKING MARKET SIZE, BY TESTING TYPE, 2018-2032 (USD MILLION)
TABLE 248. AUSTRALIA BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2018-2032 (USD MILLION)
TABLE 249. AUSTRALIA BLOOD BANKING MARKET SIZE, BY COLLECTION METHOD, 2018-2032 (USD MILLION)
TABLE 250. AUSTRALIA BLOOD BANKING MARKET SIZE, BY APHERESIS COLLECTION, 2018-2032 (USD MILLION)
TABLE 251. AUSTRALIA BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 252. AUSTRALIA BLOOD BANKING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 253. SOUTH KOREA BLOOD BANKING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 254. SOUTH KOREA BLOOD BANKING MARKET SIZE, BY BLOOD COMPONENT TYPE, 2018-2032 (USD MILLION)
TABLE 255. SOUTH KOREA BLOOD BANKING MARKET SIZE, BY TESTING TYPE, 2018-2032 (USD MILLION)
TABLE 256. SOUTH KOREA BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2018-2032 (USD MILLION)
TABLE 257. SOUTH KOREA BLOOD BANKING MARKET SIZE, BY COLLECTION METHOD, 2018-2032 (USD MILLION)
TABLE 258. SOUTH KOREA BLOOD BANKING MARKET SIZE, BY APHERESIS COLLECTION, 2018-2032 (USD MILLION)
TABLE 259. SOUTH KOREA BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 260. SOUTH KOREA BLOOD BANKING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 261. BRAZIL BLOOD BANKING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 262. BRAZIL BLOOD BANKING MARKET SIZE, BY BLOOD COMPONENT TYPE, 2018-2032 (USD MILLION)
TABLE 263. BRAZIL BLOOD BANKING MARKET SIZE, BY TESTING TYPE, 2018-2032 (USD MILLION)
TABLE 264. BRAZIL BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2018-2032 (USD MILLION)
TABLE 265. BRAZIL BLOOD BANKING MARKET SIZE, BY COLLECTION METHOD, 2018-2032 (USD MILLION)
TABLE 266. BRAZIL BLOOD BANKING MARKET SIZE, BY APHERESIS COLLECTION, 2018-2032 (USD MILLION)
TABLE 267. BRAZIL BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 268. BRAZIL BLOOD BANKING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 269. MEXICO BLOOD BANKING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 270. MEXICO BLOOD BANKING MARKET SIZE, BY BLOOD COMPONENT TYPE, 2018-2032 (USD MILLION)
TABLE 271. MEXICO BLOOD BANKING MARKET SIZE, BY TESTING TYPE, 2018-2032 (USD MILLION)
TABLE 272. MEXICO BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2018-2032 (USD MILLION)
TABLE 273. MEXICO BLOOD BANKING MARKET SIZE, BY COLLECTION METHOD, 2018-2032 (USD MILLION)
TABLE 274. MEXICO BLOOD BANKING MARKET SIZE, BY APHERESIS COLLECTION, 2018-2032 (USD MILLION)
TABLE 275. MEXICO BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 276. MEXICO BLOOD BANKING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 277. RUSSIA BLOOD BANKING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 278. RUSSIA BLOOD BANKING MARKET SIZE, BY BLOOD COMPONENT TYPE, 2018-2032 (USD MILLION)
TABLE 279. RUSSIA BLOOD BANKING MARKET SIZE, BY TESTING TYPE, 2018-2032 (USD MILLION)
TABLE 280. RUSSIA BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2018-2032 (USD MILLION)
TABLE 281. RUSSIA BLOOD BANKING MARKET SIZE, BY COLLECTION METHOD, 2018-2032 (USD MILLION)
TABLE 282. RUSSIA BLOOD BANKING MARKET SIZE, BY APHERESIS COLLECTION, 2018-2032 (USD MILLION)
TABLE 283. RUSSIA BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 284. RUSSIA BLOOD BANKING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 285. SPAIN BLOOD BANKING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 286. SPAIN BLOOD BANKING MARKET SIZE, BY BLOOD COMPONENT TYPE, 2018-2032 (USD MILLION)
TABLE 287. SPAIN BLOOD BANKING MARKET SIZE, BY TESTING TYPE, 2018-2032 (USD MILLION)
TABLE 288. SPAIN BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2018-2032 (USD MILLION)
TABLE 289. SPAIN BLOOD BANKING MARKET SIZE, BY COLLECTION METHOD, 2018-2032 (USD MILLION)
TABLE 290. SPAIN BLOOD BANKING MARKET SIZE, BY APHERESIS COLLECTION, 2018-2032 (USD MILLION)
TABLE 291. SPAIN BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 292. SPAIN BLOOD BANKING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)

Companies Mentioned

The companies featured in this Blood Banking market report include:
  • Abbott Laboratories
  • Arctiko A/S
  • BAG Diagnostics GmbH
  • Baxter International Inc.
  • Beckman Coulter, Inc.
  • Becton Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Cardinal Health, Inc.
  • Cerus Corporation
  • F. Hoffmann-La Roche Ltd.
  • Fresenius Kabi AG
  • Grifols S.A.
  • Haemonetics Corporation
  • Helmer Scientific, Inc.
  • ICU Medical, Inc.
  • Immucor, Inc.
  • JMS Transfusion Technology CO., LTD.
  • Labcold Ltd.
  • Macopharma SA
  • Nipro Corporation
  • QuidelOrtho Corporation
  • Sarstedt AG & Co. KG
  • Siemens Healthineers AG
  • Span Healthcare Private Limited
  • Terumo BCT, Inc.
  • Thermo Fisher Scientific Inc.
  • Tulip Diagnostics (P) Ltd.
  • WellSky Corporation

Table Information